Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic Patients
Department of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Province Key Laboratory of Translational Research for Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, China
1 other identifier
interventional
100
1 country
1
Brief Summary
Diabetes mellitus is a chronic metabolic disease associated with a high rate of disability and mortality. Prediabetes is the intermediate stage from normal blood glucose to diabetes. Reversal of prediabetes can help reduce the incidence of related complications and reduce premature mortality. Therefore, the early treatment of prediabetes is crucial, detection and effective management of this large population in time is the key to prevent diabetes. Overweight/obesity is one of the key risk factors leading to prediabetes and diabetes. In order to delay the progression of prediabetes and prevent related complications, weight loss is a key strategy to reverse prediabetes in overweight/obese patients. Lifestyle intervention is the first-line treatment for weight loss and is the most suitable intervention method. Although weight loss has been shown to have many metabolic benefits, it is a great challenge in the real world due to the long-term and complex of weight management. In order to further optimize the weight loss treatment of prediabetic patients, the study apply the mobile internet intelligent healthcare big data technology, 100 overweight/obese prediabetic patients who met the enrollment conditions were randomly divided into control group and intervention group by 1:1, with 50 patients in each group. The control group was treated according to the traditional diagnosis and treatment mode, and the diagnosis and treatment plan was formulated by the endocrinologist, and the diet education was conducted by the dietitian, and the individualized diet plan was formulated. Given a calorie-restricted diet, it is recommended to reduce daily energy intake by 500kcal on the basis of requirement. At least 150 minutes of moderate-intensity exercise per week is recommended. After the visit, the patient underwent follow-up self-weight monitoring and diet management outside the hospital. The intervention group was managed by co-management of three disciplines (endocrinologists, dietitians and weight managers). The three disciplines team tracked and assessed the patients' daily diet and weight changes, and gave guidance. The duration of intervention was 6 months. To explore the impact of the new model of mobile internet healthcare and "three disciplines co-management" on overweight/obese prediabetic patients, and whether it can improve the weight, glycemic and lipid metabolism and insulin resistance, and compare the reversal rate of prediabetes in the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2023
CompletedFirst Submitted
Initial submission to the registry
November 17, 2023
CompletedFirst Posted
Study publicly available on registry
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedNovember 28, 2023
November 1, 2023
1.9 years
November 17, 2023
November 22, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Change of weight
Whether there was a significant difference in weight change between the intervention and control groups
After 6 months of intervention, the change of weight was compared between the two groups
Reversal rate of prediabetes
Whether there was a significant difference in the reversal rate of prediabetes between the intervention and control groups
After 6 months of intervention, the reversal rate of prediabetes was compared between the two groups
Change of homeostasis model assessment-insulin resistance(HOMA-IR)
Whether there was a significant difference in HOMA-IR change between the intervention and control groups
After 6 months of intervention, the change of HOMA-IR was compared between the two groups
Secondary Outcomes (4)
Change of BMI
After 6 months of intervention, the change of BMI was compared between the two groups
Change of waistline
After 6 months of intervention, the change of waistline was compared between the two groups
Change of serum lipid level
After 6 months of intervention, the change of serum lipid level was compared between the two groups
Change of hepatic steatosis value
After 6 months of intervention, the change of hepatic steatosis value was compared between the two groups
Study Arms (2)
Mobile internet healthcare treatment and "three disciplines co-management"
EXPERIMENTAL100 patients who met the enrollment conditions were randomly divided into control group and intervention group by 1:1. The intervention group adopted the intervention of mobile Internet healthcare and "co-management of three disciplines" (endocrinologists, dietitians and weight managers). The three disciplines team tracked and assessed the patients' daily diet and weight changes. The duration of intervention was 6 months.
Traditional diagnosis and treatment mode
EXPERIMENTAL100 patients who met the enrollment conditions were randomly divided into control group and intervention group by 1:1. The control group was treated according to the traditional mode: the diagnosis and treatment plan was formulated by the endocrinologist, and the diet education was conducted by the dietitian, and the individualized diet plan was formulated. Given a calorie-restricted diet, it is recommended to reduce daily energy intake by 500kcal on the basis of requirement. At least 150 minutes of moderate-intensity exercise per week is recommended. After the visit, the patient underwent follow-up self-weight monitoring and diet management outside the hospital.
Interventions
"co-management of three disciplines": Endocrinologist: Assess disease status and rule out secondary obesity; Identify the causes of overweight/obesity and the status and extent of associated diseases; receive patients for return visits. Timely reply to patients' questions on the mobile medical platform, and timely adjust medication plans according to changes in patients' conditions. Dietitians: Conduct diet assessment, develop personalized medicine nutrition treatment plan and provide daily real-time guidance and follow up patients' daily diet outside the hospital. Weight managers: Establish weight loss record for patients, guide the installation and use of mobile medical Application , including weight monitoring, real-time uploading of daily diet and online interactive consultation; Follow up patients' weight changes; Assist patients in making appointments for follow-up visits.
Eligibility Criteria
You may qualify if:
- ①18 years≤ Age\<70 years
- mmol/L≤ fasting blood glucose \<6.9mmol/L
- mmol/L≤2h blood glucose \<11.0mmol/L;
- Kg/m2≤BMI≤45Kg/m2
You may not qualify if:
- Diagnosed diabetes
- In the past 3 months, metformin, thiazolidinedione, acarbose and weight reduction drugs were used
- Severe infection, severe trauma or other stress
- The weight fluctuation in the past 3 months was \>5%
- Aspartate Transaminase(AST) or Alanine Aminotransferase(ALT) increased the upper limit of 3 times the normal value; Creatinine greater than 1.5 times the upper limit of normal; Estimated Glomerular Filtration Rate(eGFR) 30 ml/min / 1.73 m2 or less
- Serious cardiovascular and cerebrovascular disease in the past 6 months
- Abnormal thyroid function not controlled;
- Pregnant and breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, 361003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
xin zheng
The First Affiliated Hospital of Xiamen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The First Affiliated Hospital of Xiamen University
Study Record Dates
First Submitted
November 17, 2023
First Posted
November 28, 2023
Study Start
March 28, 2023
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
November 28, 2023
Record last verified: 2023-11